Toshikazu Akiya

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

Wasaburo Koizumi, Hiroyuki Narahara, Takuo Hara et al. · The Lancet Oncology · 2008 · 1.9K citations

Surgical Oncology, Spirits Trial, Gastrointestinal Oncology +8

Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer

Kensei Yamaguchi, T Shimamura, Ichinosuke Hyodo et al. · British Journal of Cancer · 2006 · 68 citations · Full text

Randomized phase III study of S-1 alone versus S-1 + cisplatin in the treatment for advanced gastric cancer (The SPIRITS trial) <i>SPIRITS:</i> S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer

H. Narahara, Wasaburo Koizumi, Takuo Hara et al. · Journal of Clinical Oncology · 2007 · 52 citations

Cancer Therapeutics, Spirits Trial, Gastrointestinal Oncology +15

A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci

Wasaburo Koizumi, Minoru Kurihara, T Sasai et al. · Cancer · 1993 · 45 citations

Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study

Wasaburo Koizumi, Toshikazu Akiya, Atsushi Satō et al. · Cancer Chemotherapy and Pharmacology · 2009 · 42 citations

Geriatric Oncology, Elderly Patients, Gastrointestinal Oncology +9